Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Wadkins

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|July 24, 2021
Early Functional Impairment in Experimental Glaucoma Is Accompanied by Disruption of the GABAergic System and Inceptive NeuroinflammationOliver W Gramlich, Cheyanne R Godwin, David Wadkins, et al.
Experimental Eye Research|February 17, 2021
Circumferential trabecular meshwork cell density in the human eyeMarkus H Kuehn, Janice A Vranka, David Wadkins, et al.
Acta Neuropathologica Communications|February 8, 2024
Loss of Sarm1 reduces retinal ganglion cell loss in chronic glaucomaHuilan Zeng, Jordan E Mayberry, David Wadkins, et al.
Biomolecules|February 25, 2022
Systemic Treatment with Pioglitazone Reverses Vision Loss in Preclinical Glaucoma ModelsHuilan Zeng, Alina V Dumitrescu, David Wadkins, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|July 24, 2021
Early Functional Impairment in Experimental Glaucoma Is Accompanied by Disruption of the GABAergic System and Inceptive NeuroinflammationOliver W Gramlich, Cheyanne R Godwin, David Wadkins, et al.
Experimental Eye Research|February 17, 2021
Circumferential trabecular meshwork cell density in the human eyeMarkus H Kuehn, Janice A Vranka, David Wadkins, et al.
Acta Neuropathologica Communications|February 8, 2024
Loss of Sarm1 reduces retinal ganglion cell loss in chronic glaucomaHuilan Zeng, Jordan E Mayberry, David Wadkins, et al.
Biomolecules|February 25, 2022
Systemic Treatment with Pioglitazone Reverses Vision Loss in Preclinical Glaucoma ModelsHuilan Zeng, Alina V Dumitrescu, David Wadkins, et al.
Pageof 1